Insights & Events

Firm partner Eric Lasker will speak at DRI’s 2026 Drug and Medical Device Seminar in Boston, MA on May 22, 2026. The session — “Raising the Bar on Experts: Litigating Under Amended Rule 702 in Drug & Device Cases” — will dig into how amended Rule 702 is reshaping expert admissibility. The panel will break down recent federal and state decisions excluding expert testimony, examine the growing alignment of state evidentiary rules with the federal standard, and offer practical strategies for challenging unreliable or unqualified experts. If you’re navigating expert issues in drug and device litigation, this discussion will deliver concrete tools to strengthen your motions and trial practice.

The program will also explore how these developments are influencing case strategy more broadly, from Rule 702 briefing to trial preparation. Panelists will highlight emerging trends in judicial gatekeeping, including courts’ increasing focus on methodological rigor and the sufficiency of an expert’s factual foundation. Attendees will gain a clearer understanding of how to anticipate and address Rule 702 challenges in a rapidly evolving legal landscape, as well as insights into how these shifts may shape expert-intensive litigation in the future.